New technology, novel therapies on horizon in type 1 diabetes
October 15, 2026 10 min watch Add topic to email alerts Receive an email when new articles are posted on Please provide your email…
October 15, 2026 10 min watch Add topic to email alerts Receive an email when new articles are posted on Please provide your email…
U.K. FreeDM2 randomized controlled trial: At four months, people using Libre technology had a 0.6% greater reduction in HbA1c and 2.5 more hours a day in the healthy range vs.…
Image Credit: freepik Lately, you have been experiencing a bad mood with low energy, cravings, and even mood swings. But what’s really going on? Blood sugar might be a major…
LAS VEGAS, Dec. 16, 2025 /CNW/ — Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), an emerging biotechnology company focused on developing cell-based therapies for diabetes and age-related disorders,…
The most consistent benefits for adults with type 1 diabetes (T1D) can be seen with a combination of a low-carbohydrate diet, education, carbohydrate counting, and modern diabetes technology, such as…
Bahari, N. I. et al. Issues and challenges in the primary prevention of type 2 diabetes mellitus: A systematic review. J. Prev. 44, 105–125 (2023). Article Google Scholar Roman, S.…
NASHVILLE, Tenn. (Ivanhoe Newswire) — The number of adults living with diabetes worldwide has surpassed 800 million, and the World Health Organization calls Type 2 diabetes an epidemic. But new…
PLEASANTON, Calif., Nov. 4, 2025 /PRNewswire/ — Aqua Medical, a company advancing Endoscopic Metabolic Restoration for type 2 diabetes, today announced that the U.S. Food and Drug Administration (FDA) has…
Mobile, Alabama (WALA) – USA Health is currently providing Histotripy, a non-invasive medical procedure that breaks down Gulf tumors, to patients in the Gulf Coast and surrounding areas. This morning,…
Abbott's Libre® Technology is the first continuous glucose monitor associated with reduced hospitalizations for cardiac complications in diabetic patients New data reveal a 78% reduction in cardiovascular disease-related hospitalizations in…